Experts Look At The Meaning Of Myriad Case, One Year Later

Cal Irvine law school myriad conf Sept 2014

IRVINE, CALIFORNIA – Experts gathered here last week addressed the question of – one year later – what does the United States Supreme Court’s decision on human gene patents mean for scientific research and patent policy?

Biosimilar Medicines Need Strong Regulation, IP Crucial For Innovation, Pharma Says

Biosimilar medicines might prove to be a new reservoir for innovation for the pharmaceutical industry. However, the complexity of their manufacture needs a stringent regulatory framework, according to the industry.

New Proposal To Keep Indigenous Peoples On WIPO Traditional Knowledge Committee

WIPO IGC

A group of countries has submitted a new proposal to the upcoming meeting of the World Intellectual Property Organization budget committee to allow the continued participation of indigenous peoples representatives in WIPO’s committee on traditional knowledge and genetic resources.

World Drug Regulatory Authorities Meet In Brazil; Biosimilars In Focus

Drug regulatory authorities are meeting this week in Rio de Janeiro, Brazil to discuss global regulatory issues such as vaccine regulation, falsified products, and pharmacovigilance. A “pre-conference” focused on biosimilars, with civil society warning on barriers to access to those products.

Human Eggs That Can’t Develop Into Human Beings Should Be Patentable, EU High Court Advisor Says

Unfertilised human eggs that can’t develop into human beings are generally not “human embryos” within the meaning of the EU directive on the legal protection of biotechnological inventions, a 17 July European Court of Justice Advocate General opinion said. The opinion is good news for researchers into stem cell therapies, said a member of the industry group IP Federation, who added he hopes it will be upheld by the ECJ. But one biotech civil society member said the ruling, if it stands, could be abused.

With 51 Ratifications, Nagoya Protocol To Enter Into Force In October

The Nagoya Protocol on access and benefit-sharing of genetic resources will enter into force on 12 October, following the ratification of 12 more countries last week.

360 Applicants Bid For Top WIPO Posts; Selection Process Underway

The World Intellectual Property Organization is currently engaged in an unprecedented process for the selection of the new top management team to serve under recently re-elected Director General Francis Gurry. The open call for applicants resulted in some 360 applications from around the world, including from the upper echelons of WIPO itself, according to sources.

Seed Treaty Celebrates Ten Year Anniversary; Focus On Funding, Collaborations

The International Seed Treaty held a celebratory high-level event recently to mark the tenth anniversary of its entry into force.